Indeno [1,2-c]pyrazol-4-ones and their uses
AssigneeBristol-Myers Squibb Pharma Company
InventorsDavid A. Nugiel, David J. Carini, Susan V. DiMeo, Eddy W. Yue
Life of this patent
Estimating the term…
Loading patent…
AssigneeBristol-Myers Squibb Pharma Company
InventorsDavid A. Nugiel, David J. Carini, Susan V. DiMeo, Eddy W. Yue
Estimating the term…
The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I): 1 that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-9 and their regulatory subunits know as cyclins A-H. This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.
A compound according to formula (I):
A method of inhibiting the division of a cell which comprises contacting the cell with a composition comprising a pharmaceutically acceptable carrier and an effective amount of a compound of the formula (I):
Dependencies are inferred from the claim text.